Literature DB >> 37684

Bilirubin acidity. Titrimetric and 13C NMR studies.

P E Hansen, H Thiessen, R Brodersen.   

Abstract

Acidimetric titration of bilirubin IX-alpha, dissolved in excess aqueous sodium hydroxide, showed that two protons are dissociated with pK values well below 7 and that one or several additional acidic groups titrate with pK around 12.9. Precipitation of the nearly insoluble acid precluded determination of the two lower pK values by titration in aqueous solution. In dimethyl sulfoxide solution, four acidic protons were demonstrated, titrating two by two without precipitation. 13C NMR spectra of bilirubin IX-alpha were recorded and complete assignments were made by comparison with the spectra of bilirubin XIII-alpha and mesobilirubin etc. Such spectra, recorded after addition of 2 and 4 mol of base per mol of bilirubin IX-alpha, showed that both carboxyl groups are titrated by the first 2 mol of base, and both lactams by the following 2 mol of base. Cotitrations of bilirubin IX-alpha with other acids, o- and m-hydroxybenzoic acid and 2-pyridone, were used to determine relative pK values in dimethyl sulfoxide solution, and pK values for the four acidic protons of bilirubin IX-alpha in aqueous solution were calculated from the Born equation. Both carboxyl groups exhibited pK = 4.4, and both lactams pK = 13.0, in good agreement with values expected from the chemical structure of the bilirubin molecule. The implications of these findings for understanding the mechanism of bilirubin neurotoxicity are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37684     DOI: 10.3891/acta.chem.scand.33b-0281

Source DB:  PubMed          Journal:  Acta Chem Scand B        ISSN: 0302-4369


  10 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Dissociation constants of water-insoluble carboxylic acids by 13C-NMR. pK(a)s of mesobiliverdin-XIII alpha and mesobilirubin-XIII alpha.

Authors:  D A Lightner; D L Holmes; A F McDonagh
Journal:  Experientia       Date:  1996-06-15

4.  Conformational changes in the bilirubin-human serum albumin complex at extreme alkaline pH.

Authors:  B Honoré; P C Frandsen
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

Review 5.  Review: Bilirubin pKa studies: new models and theories indicate high pKa values in water, dimethylformamide and DMSO.

Authors:  Pasupati Mukerjee; J Donald Ostrow
Journal:  BMC Biochem       Date:  2010-03-29       Impact factor: 4.059

Review 6.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

7.  Structure and thermal interconversion of cyclobilirubin IX alpha.

Authors:  S Onishi; I Miura; K Isobe; S Itoh; T Ogino; T Yokoyama; T Yamakawa
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  Revalidation and rationale for high pKa values of unconjugated bilirubin.

Authors:  J Donald Ostrow; Pasupati Mukerjee
Journal:  BMC Biochem       Date:  2007-05-02       Impact factor: 4.059

9.  Physico-chemical characterization of bilirubin-10-sulfonate and comparison of its acid-base behavior with unconjugated bilirubin.

Authors:  Adam Čepa; Veronika Dejmková; Ladislav Lešetický; Ivan Jelínek; Stanislav Smrček; Martin Štícha; Jana Jašprová; Marie Urbanová; Iryna Goncharova; Martin Dračínský; Eliška Procházková; Donald J Ostrow; Libor Vítek
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

10.  Isoextraction studies of partition of UCB between chloroform and aqueous solution.

Authors:  J S Hahm; K N Park
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.